{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T04:21:49Z","timestamp":1782966109218,"version":"3.54.5"},"reference-count":44,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004628","name":"MedImmune","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004628","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.mcna.2011.09.001","type":"journal-article","created":{"date-parts":[[2011,11,14]],"date-time":"2011-11-14T14:43:50Z","timestamp":1321281830000},"page":"1115-1124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Asthma"],"prefix":"10.1016","volume":"95","author":[{"given":"Rodolfo M.","family":"Pascual","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2011.09.001_bib1","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1542\/peds.109.5.857","article-title":"Racial\/ethnic variation in asthma status and management practices among children in managed Medicaid","volume":"109","author":"Lieu","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.mcna.2011.09.001_bib2","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1164\/rccm.201003-0321UP","article-title":"Update in asthma 2009","volume":"181","author":"Moore","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mcna.2011.09.001_bib3","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11882-005-0087-8","article-title":"The role of regulatory T lymphocytes in asthma pathogenesis","volume":"5","author":"Robinson","year":"2005","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/j.mcna.2011.09.001_bib4","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1111\/j.1365-2222.2009.03301.x","article-title":"Regulatory T cells and asthma","volume":"39","author":"Robinson","year":"2009","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"10.1016\/j.mcna.2011.09.001_bib5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.jaci.2011.06.002","article-title":"What effect does asthma treatment have on airway remodeling? Current perspectives","volume":"128","author":"Durrani","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.mcna.2011.09.001_bib6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jaci.2005.07.011","article-title":"Airway remodeling contributes to the progressive loss\u00a0of lung function in asthma: an overview","volume":"116","author":"Pascual","year":"2005","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.mcna.2011.09.001_bib7","series-title":"CIinical asthma","first-page":"67","article-title":"Diagnosis of asthma in adults","author":"Lugogo","year":"2008"},{"key":"10.1016\/j.mcna.2011.09.001_bib8","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1164\/ajrccm.161.1.ats11-99","article-title":"Guidelines for methacholine and exercise challenge testing-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999","volume":"161","author":"Crapo","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mcna.2011.09.001_bib9","series-title":"Clinical asthma","first-page":"189","article-title":"Management of persistent asthma in adults","author":"Pascual","year":"2008"},{"key":"10.1016\/j.mcna.2011.09.001_bib10","series-title":"National Asthma Education and Prevention Program, Expert Panel Report 3, guidelines for the diagnosis and management of asthma","author":"Busse","year":"2007"},{"key":"10.1016\/j.mcna.2011.09.001_bib11","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1034\/j.1399-3003.1999.14d29.x","article-title":"Development and validation of a questionnaire to measure asthma control","volume":"14","author":"Juniper","year":"1999","journal-title":"Eur Respir J"},{"key":"10.1016\/j.mcna.2011.09.001_bib12","first-page":"265","article-title":"A\u00a0systematic review of risk factors associated with near-fatal and fatal asthma","volume":"12","author":"Alvarez","year":"2005","journal-title":"Can Respir J"},{"key":"10.1016\/j.mcna.2011.09.001_bib13","series-title":"MCR Vision. In: Global strategy for asthma management and prevention","author":"O'Byrne","year":"2006"},{"key":"10.1016\/j.mcna.2011.09.001_bib14","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1164\/ajrccm.162.6.ats9-00","article-title":"Proceedings of the ATS workshop on refractory asthma: current understanding, recommendations, and unanswered questions. American Thoracic Society","volume":"162","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mcna.2011.09.001_bib15","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1067\/mai.2001.117880","article-title":"Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma","volume":"108","author":"Busse","year":"2001","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.mcna.2011.09.001_bib16","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1056\/NEJM199711133372002","article-title":"A\u00a0comparison of low-dose inhaled budesonide plus theophylline and high-dose inhaled budesonide for moderate asthma","volume":"337","author":"Evans","year":"1997","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2011.09.001_bib17","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0140-6736(94)92996-3","article-title":"Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group","volume":"344","author":"Greening","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.mcna.2011.09.001_bib18","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.rmed.2009.11.022","article-title":"Add-on montelukast in inadequately controlled asthma patients in a 6-month open-label study: the MONtelukast In Chronic Asthma (MONICA) study","volume":"104","author":"Virchow","year":"2010","journal-title":"Respir Med"},{"key":"10.1016\/j.mcna.2011.09.001_bib19","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1001\/jama.285.20.2583","article-title":"Long-acting beta2-agonist monotherapy vs continued therapy with inhaled corticosteroids in patients with persistent asthma: a randomized controlled trial","volume":"285","author":"Lazarus","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2011.09.001_bib20","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1378\/chest.129.1.15","article-title":"The Salmeterol Multicenter Asthma Research Trial: a comparison of usual pharmacotherapy for asthma or usual pharmacotherapy plus salmeterol","volume":"129","author":"Nelson","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.mcna.2011.09.001_bib21","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.anai.2011.03.005","article-title":"Persistence of effectiveness of bronchial thermoplasty in patients with severe asthma","volume":"107","author":"Castro","year":"2011","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.mcna.2011.09.001_bib22","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1164\/rccm.200903-0354OC","article-title":"Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial","volume":"181","author":"Castro","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mcna.2011.09.001_bib23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1056\/NEJMoa1103319","article-title":"Active albuterol or placebo, sham acupuncture, or no intervention in asthma","volume":"365","author":"Wechsler","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2011.09.001_bib24","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.jaci.2009.05.041","article-title":"Randomized trial of the effect of drug presentation on asthma outcomes: the American Lung Association Asthma Clinical Research Centers","volume":"124","author":"Wise","year":"2009","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.mcna.2011.09.001_bib25","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJMoa0806290","article-title":"Efficacy of esomeprazole for treatment of poorly controlled asthma","volume":"360","author":"Mastronarde","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2011.09.001_bib26","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1164\/rccm.200511-1746OC","article-title":"Smoking affects response to inhaled corticosteroids or leukotriene receptor antagonists in asthma","volume":"175","author":"Lazarus","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mcna.2011.09.001_bib27","doi-asserted-by":"crossref","first-page":"e18574","DOI":"10.1371\/journal.pone.0018574","article-title":"Detrimental effects of environmental tobacco smoke in relation to asthma severity","volume":"6","author":"Comhair","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.mcna.2011.09.001_bib28","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa011961","article-title":"The safety of inactivated influenza vaccine in adults and children with asthma","volume":"345","year":"2001","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2011.09.001_bib29","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1056\/NEJMoa0904023","article-title":"Severe respiratory disease concurrent with the circulation of H1N1 influenza","volume":"361","author":"Chowell","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2011.09.001_bib30","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1056\/NEJMoa0906695","article-title":"Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009","volume":"361","author":"Jain","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2011.09.001_bib31","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jaci.2010.11.015","article-title":"Heterogeneity of severe asthma in childhood: confirmation by cluster analysis of children in the National Institutes of Health\/National Heart, Lung, and Blood Institute Severe Asthma Research Program","volume":"127","author":"Fitzpatrick","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.mcna.2011.09.001_bib32","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1164\/rccm.200711-1754OC","article-title":"Cluster analysis and clinical asthma phenotypes","volume":"178","author":"Haldar","year":"2008","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mcna.2011.09.001_bib33","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.jaci.2006.11.639","article-title":"Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute\u2019s Severe Asthma Research Program","volume":"119","author":"Moore","year":"2007","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.mcna.2011.09.001_bib34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1164\/rccm.200906-0896OC","article-title":"Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program","volume":"181","author":"Moore","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mcna.2011.09.001_bib35","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200903-0392OC","article-title":"T-helper type 2-driven inflammation defines major subphenotypes of asthma","volume":"180","author":"Woodruff","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mcna.2011.09.001_bib36","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMoa0808991","article-title":"Mepolizumab and exacerbations of refractory eosinophilic asthma","volume":"360","author":"Haldar","year":"2009","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2011.09.001_bib37","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1164\/rccm.200809-1512OC","article-title":"A\u00a0randomized, double-blind, placebo-controlled study of tumor necrosis factor-alpha blockade in severe persistent asthma","volume":"179","author":"Wenzel","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mcna.2011.09.001_bib38","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1164\/rccm.200909-1448OC","article-title":"A\u00a0randomized, controlled, phase 2 study of AMG 317, an IL-4Ralpha antagonist, in patients with asthma","volume":"181","author":"Corren","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mcna.2011.09.001_bib39","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1164\/rccm.200701-085OC","article-title":"A\u00a0study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma","volume":"176","author":"Flood-Page","year":"2007","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mcna.2011.09.001_bib40","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1056\/NEJMoa1008770","article-title":"Tiotropium bromide step-up therapy for adults with uncontrolled asthma","volume":"363","author":"Peters","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.mcna.2011.09.001_bib41","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaci.2010.03.043","article-title":"Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program study","volume":"126","author":"Brehm","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.mcna.2011.09.001_bib42","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1164\/rccm.200911-1710OC","article-title":"Vitamin D levels, lung function, and steroid response in adult asthma","volume":"181","author":"Sutherland","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.mcna.2011.09.001_bib43","article-title":"A\u00a0randomized, double-blind, placebo-controlled study of the CRTH2 antagonist OC000459 in moderate persistent asthma","author":"Barnes","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.mcna.2011.09.001_bib44","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ejphar.2005.12.059","article-title":"Phosphodiesterase inhibitors in airways disease","volume":"533","author":"Fan","year":"2006","journal-title":"Eur J Pharmacol"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712511000952?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712511000952?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:42:16Z","timestamp":1758418936000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712511000952"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":44,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0025712511000952"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2011.09.001","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asthma","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2011.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}